ELANE and acute respiratory distress syndrome: We consider the recent discoveries as a step forward to understand the structural features necessary to express the inhibitory activity against human neutrophil elastase and provide new commercial drugs against chronic obstructive pulmonary disease, acute lung injury, acute respiratory distress syndrome, pulmonary fibrosis and ARDS linked to COVID-19 infection.